TT
The startup develops nano biologic therapeutics that target trained immunity to enhance immune cell production from hematopoietic organs, specifically the bone marrow and spleen. This approach aims to improve the immune response against persistent diseases such as cancer and infections.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops nano biologic therapeutics that target trained immunity to enhance immune cell production from hematopoietic organs, specifically the bone marrow and spleen. This approach aims to improve the immune response against persistent diseases such as cancer and infections.